1. Home
  2. CAL vs IMRX Comparison

CAL vs IMRX Comparison

Compare CAL & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.32

Market Cap

400.3M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.59

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAL
IMRX
Founded
1878
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.3M
340.7M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CAL
IMRX
Price
$12.32
$5.59
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$15.00
$17.20
AVG Volume (30 Days)
697.9K
753.5K
Earning Date
05-28-2026
05-04-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
$85,513,000.00
N/A
Revenue This Year
$6.10
N/A
Revenue Next Year
$1.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.46
N/A
52 Week Low
$8.80
$1.10
52 Week High
$17.53
$10.08

Technical Indicators

Market Signals
Indicator
CAL
IMRX
Relative Strength Index (RSI) 63.02 59.31
Support Level $11.71 $5.34
Resistance Level $13.55 $5.80
Average True Range (ATR) 0.69 0.28
MACD 0.20 0.05
Stochastic Oscillator 95.63 92.35

Price Performance

Historical Comparison
CAL
IMRX

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: